“VerteCore: Wearable Spinal Decompression” Mississippi medical device start-up, VerteCore Technologies LLC, has developed VerteCore Lift, a wearable orthopedic device, to innovate the way back pain is managed. The device alleviates nerve root impingement related sciatica and neurogenic intermittent claudication that results from spinal stenosis with mobile, non-surgical decompression. In this interview, co-founder and CEO, Paul Leake talks about his experiences in co-founding the company and what’s next for VerteCore.
“LabReady, Set, Go: Accurately Diagnosing Infections Faster and From Home” Houston medical device diagnostics start-up, Vax-Immune Diagnostics LLC, has developed LabReady, a hand-held, portable, disposable device. This novel diagnostic platform device was designed to revolutionize the identification process of infectious disease. In this interview, co-founder, President, and CTO Leonard Weisman, MD talks about his experiences in co-founding the company and what’s next for Vax-Immune.
“A Hole in the Heart Alleviates HF Symptoms” Houston medical device start-up, Alleviant Medical, is developing a novel transcatheter technology that applies left atrial decompression to provide symptomatic relief for congestive heart failure. In this interview, co-founder and CMO Jacob Kriegel, MD talks about his experiences in co-founding the company and what’s next for Alleviant Medical.
“NeuroQore’s Electromagnetics: A New Way to Treat Depression & Neurobehavioral Disorders” Silicon Valley medical device start-up, NeuroQore Inc., has developed a novel platform technology that it believes can be applied to many neurobehavioral disorders and could provide rapid treatment for major depressive disorder (MDD). The team is striving to put an end to the most devastating of all endings: suicide. In this interview, co-founder and CEO Mehran Talebinejad talks about his experiences in co-founding the company and what’s next for NeuroQore.
Paris-based start-up AblaCare is developing an innovative device and minimally-invasive procedure for the treatment of Polycystic Ovary Syndrome (PCOS) related infertility which they believe would be less risky, less invasive, and less costly than current solutions. In this candid interview filmed onsite at MedTech Strategist’s Innovation Summit Dublin, Ireland with Analyst Kayleen Brown, CEO Anne Osdoit and COO Marion Gasperment talk about their current priorities and their experiences so far on their start-up journey.